PubMed · 2026
GLP-1 receptor agonist discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes: a retrospective cohort study
Ceriello A, Prattichizzo F, Lucisano G, et al. (2026). GLP-1 receptor agonist discontinuation and cardiovascular events and all-cause mortality in people with type 2 diabetes: a retrospective cohort study. Lancet Reg Health Eur.
Lancet Reg Health Eur
Source: https://doi.org/10.1016/j.lanepe.2026.101881
Last reviewed . By the PeptIQ team.
Peptides linked in PeptIQ Wiki
This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.